We are the first to report that circulating leukocytes from people with schizophrenia have alterations in the expression of several NF-κB pathway mRNAs that can be grouped into three distinct classes: 1) cell surface receptors, 2) intracellular kinases and 3) regulatory subunits. This evidence concerns the gene NFKB1 and schizophrenia.